239 related articles for article (PubMed ID: 34057082)
21. High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3×Tg-AD Mouse Model.
Zhang J; Hua XF; Gu J; Chen F; Gu J; Gong CX; Liu F; Dai CL
J Alzheimers Dis; 2020; 74(3):851-864. PubMed ID: 32116254
[TBL] [Abstract][Full Text] [Related]
22. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
[TBL] [Abstract][Full Text] [Related]
23. Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase.
Liu B; Kou J; Li F; Huo D; Xu J; Zhou X; Meng D; Ghulam M; Artyom B; Gao X; Ma N; Han D
Aging (Albany NY); 2020 May; 12(9):8622-8639. PubMed ID: 32392535
[TBL] [Abstract][Full Text] [Related]
24. Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
Ibi D; Hirashima K; Kojima Y; Sumiya K; Kondo S; Yamamoto M; Ando T; Hiramatsu M
J Alzheimers Dis; 2021; 79(2):639-652. PubMed ID: 33337369
[TBL] [Abstract][Full Text] [Related]
25. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
26. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
[TBL] [Abstract][Full Text] [Related]
27. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
28. Longan (Dimocarpus longan Lour.) Aril ameliorates cognitive impairment in AD mice induced by combination of D-gal/AlCl
Li H; Lei T; Zhang J; Yan Y; Wang N; Song C; Li C; Sun M; Li J; Guo Y; Yang J; Kang T
J Ethnopharmacol; 2021 Mar; 267():113612. PubMed ID: 33249246
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin Signaling can Rescue Cognition and Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Z; Yu Z; Yuan Y; Yang J; Wang S; Ma H; Hao L; Ma J; Li Z; Zhang Z; Hölscher C
Mol Neurobiol; 2023 Sep; 60(9):5067-5089. PubMed ID: 37247071
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.
Baazaoui N; Iqbal K
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291618
[TBL] [Abstract][Full Text] [Related]
31. Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer's disease.
Ma QH; Jiang LF; Mao JL; Xu WX; Huang M
Mol Med Rep; 2018 Mar; 17(3):4113-4119. PubMed ID: 29257340
[TBL] [Abstract][Full Text] [Related]
32. Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.
Wiseman AL; Briggs CA; Peritt A; Kapecki N; Peterson DA; Shim SS; Stutzmann GE
J Alzheimers Dis; 2023; 91(1):273-290. PubMed ID: 36442195
[TBL] [Abstract][Full Text] [Related]
33. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
34. Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.
Xiao H; Li H; Song H; Kong L; Yan X; Li Y; Deng Y; Tai H; Wu Y; Ni Y; Li W; Chen J; Yang J
J Ethnopharmacol; 2020 Sep; 259():112957. PubMed ID: 32416248
[TBL] [Abstract][Full Text] [Related]
35. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
Baazaoui N; Flory M; Iqbal K
J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
[TBL] [Abstract][Full Text] [Related]
36. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
37. A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2018; 62(3):1211-1218. PubMed ID: 29562539
[TBL] [Abstract][Full Text] [Related]
38. Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer's disease.
Chakroborty S; Hill ES; Christian DT; Helfrich R; Riley S; Schneider C; Kapecki N; Mustaly-Kalimi S; Seiler FA; Peterson DA; West AR; Vertel BM; Frost WN; Stutzmann GE
Mol Neurodegener; 2019 Jan; 14(1):7. PubMed ID: 30670054
[TBL] [Abstract][Full Text] [Related]
39. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.
Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H
Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019
[TBL] [Abstract][Full Text] [Related]
40. Young blood plasma reduces Alzheimer's disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice.
Zhao Y; Qian R; Zhang J; Liu F; Iqbal K; Dai CL; Gong CX
Alzheimers Res Ther; 2020 Jun; 12(1):70. PubMed ID: 32513253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]